Affiliation:
1. Department of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans LA
2. Department of Medicine Tulane University School of Medicine New Orleans LA
Abstract
Abstract
Medicine and public health have traditionally separated the prevention and treatment of communicable and noncommunicable diseases. The coronavirus disease 2019 (
COVID
‐19) pandemic has challenged this paradigm, particularly in the setting of cardiovascular disease (
CVD
). Overall, individuals with underlying
CVD
who acquire severe acute respiratory syndrome coronavirus 2 experience up to a 10‐fold higher case‐fatality rate compared with the general population. Although the impact of the pandemic on cardiovascular health continues to evolve, few have defined this association from a frontline, public health perspective of populations disproportionately affected by
CVD
and
COVID
‐19. Louisiana is ranked within the bottom 5 states for cardiovascular health, and it is home to several parishes that have experienced among the highest
COVID
‐19 case‐fatality rates nationally. Herein, we review
CVD
prevention and implications of
COVID
‐19 in New Orleans, LA, a city holding a sobering yet resilient history with previous public health disasters. In particular, we discuss potential pandemic‐driven changes in access to health care, preventive pharmacotherapy, and lifestyle behaviors, all of which may adversely affect
CVD
prevention and management, while amplifying racial disparities. Through this process, we highlight proposed recommendations for how
CVD
prevention efforts can be improved in the midst of the current
COVID
‐19 pandemic and future public health crises.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献